| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $613.5M | +1.9% |
| Cost of Revenue | $347.3M | -4.5% |
| Gross Profit | $266.2M | +11.6% |
| R&D Expense | $18.8M | +0.6% |
| SG&A Expense | $146.1M | +10.6% |
| Operating Income | $82.5M | +462.3% |
| Pre-tax Income | $28.6M | +209.0% |
| Income Tax | $9.5M | +412.7% |
| Net Income | $19.2M | +182.5% |
| EPS (Basic) | $0.16 | +180.0% |
| EPS (Diluted) | $0.16 | +180.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.2M | -33.6% |
| Accounts Receivable | $57.9M | +60.3% |
| Inventory | $205.7M | +6.8% |
| Current Assets | $316.2M | +6.3% |
| Total Assets | $1.16B | +2.7% |
| Current Liabilities | $115.1M | +21.0% |
| Long-term Debt | $516.1M | -6.6% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $46.2M | -1.4% |
| Capital Expenditures | $12.3M | +81.1% |
| Investing Cash Flow | -$32.2M | -1694.7% |
| Financing Cash Flow | -$32.6M | +5.8% |
| Free Cash Flow | $33.9M | -15.5% |
| $715.0M |
| +0.4% |
| Stockholders' Equity | $448.9M | +6.6% |